Home
 
Companies
 
Patients
 
Investigators
 
Trials & Research
 
Regulatory
 
Therapeutics
News
Features
Commentary
People
Events
White Papers
Home - Commentary
MHRA Guidance; impacts for the central lab
09 August 2010
Our quality assurance officer in Europe, Elizabeth Atkin , and I attended the MHRA conference – GCP for Clinical Laboratories – Clinical Pursuits in York, England, at the beginning of the year. The various sessions throughout the day provided comprehensive overviews of how the clinical trials ...
As Scott Reuben faces jail, just how common is fraud in clinical trials?
22 July 2010
Last month, the prominent and pioneering anaesthesiologist Scott Reuben , chief of acute pain at Baystate Medical Centre , was sentenced to six months in prison for falsifying the data in, or entirely inventing, dozens of clinical trials. In the end, what caught Reuben was an audit of two papers ...
As wages increase, is China still a good location for clinical trials?
16 June 2010
The recent condemnation by Charles River Laboratories ' largest shareholder of that company's proposed acquisition of the leading Chinese CRO, WuXi PharmaTech , raised questions about whether companies are being too optimistic about the potential of China as a location for clinical research and the ...
Publication bias on the agenda again
03 June 2010
IQWiG , the German health technology assessment institute, has renewed its call for legislation to make the prospective registration of clinical trials mandatory and to compel trial sponsors to publish the full results of all trials in a results database. The demand comes in a new study, published ...
Decision time: how to take the EDCTP forward
10 May 2010
A proverb attributed to the Chinese philosopher Lao Tsu says: give a man a fish and you feed him for a day; teach a man to fish and you feed him for a lifetime. That sentiment could well be applied today to the provision of medicines for diseases that predominantly affect resource-poor countries, ...
Challenges and breakthroughs in IBD
30 March 2010
Inflammatory bowel disease is a term used to cover two specific conditions that are both chronic diseases that affect the gastrointestinal tract – Crohn's disease and ulcerative colitis. The main difference between them is the area of the gut that they affect. In Crohn's disease, the inflammation ...
 
 
COMPANY/ORGANISATION
 
CONDITION
 
GEOGRAPHY
 
DRUG
 
 
About Us
Getting Started
Subscribe
FREE Trial
Advertise
Awards
White Papers
EVENTS
Clinical trial supply Asia 2010
14 September 2010
Singapore
Children's Medicines Working Party
28 September 2010
London, UK
Drafting and negotiating clinical trials agreements
09 November 2010
London, UK
 
Home
General
Companies
Patients
News Features Analysis Commentary People Events
About Us Advertise Site Map Privacy Policy Terms & Conditions Subscribe
  Investigators   Trials & Research
  Regulatory   Therapeutics
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36